Skip to Content
menu

Change Life Stories

Milton Living with ATTR Amyloidosis with Cardiomyopathy

When I think about memories, I smile. My memories keep me going.

Read Milton's story

Change Life Stories

Nancy Living with ATTR Amyloidosis with Polyneuropathy

I look at my dad and think, ‘Is that what’s going to happen to me in the future?’

Ready Nancy's story

Change Life Stories

Shanna, Oren and Damian Living with Hereditary Angioedema Type 1

There’s so much uncertainty with rare disease — the best treatment is your own confidence in making the decisions that are right for you.

Read Shanna's story

News Updates

Intellia Therapeutics Receives European Union Orphan Drug Designation for NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema

Read more

Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Read more
View all news updates

Aiming to make the impossible, possible

Our
Mission

Transforming lives of people with severe diseases by developing potentially curative genome editing treatments.

Learn more

Programs
and Pipeline

Each one of us together for patients

Learn more

Full-Spectrum Approach

Opening a new era in medicine

Learn more

Join Us

See how you can change life stories with genome editing.

Learn more